Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1941 (ipragliflozin) with Insulin in Type 1 Diabetes
NCT02897219Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipragliflozin in type 1 diabetes mellitus (T1D), sponsored by Astellas Pharma. Started Aug 2016; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02897219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897219.